Acacia Research (NASDAQ:ACTG) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Acacia Research (NASDAQ:ACTG) posted its earnings results on Thursday. The business services provider reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.02, FiscalAI reports. The firm had revenue of $54.24 million for the quarter, compared to analyst estimates of $50.00 million. Acacia Research had a return on equity of 4.11% and a net margin of 7.60%.During the same quarter in the prior year, the company earned $0.25 EPS.

Here are the key takeaways from Acacia Research’s conference call:

• Benchmark drilled its first Cherokee well (online late March) at a development cost of about $11.5M, targeting >2.5x MOIC (>60% IRR) with company-record April production (over 63,000 barrels), which should begin to boost results in Q2–Q3.
• Acacia recorded a large unrealized mark-to-market hedge loss (~$9.7M) because oil hedges are struck near $70 while WTI was $101 at March 31, materially depressing GAAP net income and book value this quarter despite being non-cash.
• Deflecto completed the Portland?Dover consolidation and expects roughly $2M of annualized cost savings with benefits starting in H2 2026, though the company incurred near-term restructuring and CapEx.
• Printronix remained a steady cash generator, producing about $4.8M of cash flow over the past 12 months (~15% yield on acquisition) as it shifts toward a higher-consumables, recurring-revenue model.
• The intellectual property segment was episodic this quarter (only $0.7M revenue and a negative $3.5M adjusted EBITDA) with no Atlas-sized settlement like in Q1 2025, creating near-term volatility despite ongoing enforcement activity in R2/Atlas portfolios.

Acacia Research Stock Down 0.9%

ACTG stock traded down $0.04 during mid-day trading on Friday, reaching $4.66. The company had a trading volume of 273,452 shares, compared to its average volume of 286,798. The company has a debt-to-equity ratio of 0.10, a quick ratio of 8.64 and a current ratio of 9.18. The company has a market capitalization of $450.11 million, a price-to-earnings ratio of 20.26 and a beta of 0.49. The firm has a fifty day simple moving average of $4.79 and a 200 day simple moving average of $4.13. Acacia Research has a fifty-two week low of $3.12 and a fifty-two week high of $5.27.

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. Weiss Ratings upgraded shares of Acacia Research from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, March 13th. Wall Street Zen lowered shares of Acacia Research from a “buy” rating to a “hold” rating in a research note on Saturday, March 14th. Finally, Craig Hallum boosted their price target on shares of Acacia Research from $5.00 to $6.00 and gave the stock a “buy” rating in a research note on Thursday, March 12th. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $6.00.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in ACTG. AQR Capital Management LLC purchased a new position in shares of Acacia Research in the 1st quarter valued at about $35,000. Zions Bancorporation National Association UT purchased a new position in shares of Acacia Research in the 4th quarter valued at about $38,000. Occudo Quantitative Strategies LP purchased a new position in shares of Acacia Research in the 4th quarter valued at about $49,000. Abel Hall LLC purchased a new position in shares of Acacia Research in the 4th quarter valued at about $51,000. Finally, Verition Fund Management LLC purchased a new position in shares of Acacia Research in the 3rd quarter valued at about $65,000. Hedge funds and other institutional investors own 86.69% of the company’s stock.

Acacia Research Company Profile

Acacia Research Corporation is a publicly traded patent licensing company based in New York City. The firm specializes in acquiring patented technologies through a network of wholly owned subsidiaries and seeking licensing agreements or settlements with companies that utilize those technologies. Since its founding in 1993, Acacia has built a business model centered on identifying innovative inventions and monetizing them through patent enforcement and strategic partnerships.

The company’s activities span a broad range of technology sectors, including life sciences, medical devices, software, telecommunications and consumer electronics.